TMCnet News
Cheetah Medical: KOL Tells Attendees at 4th International Fluid Academy Scientific Meeting That Current SOC Guidelines for IV Fluid Management "Are Likely to Lead to Salt Water Drowning of These Patients"Cheetah Medical, a rapidly growing medical device company, announced today that a key opinion-leading physician, Paul E. Marik, MD, Professor of Medicine and Chief, Div. of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, told attendees at the 4th International Fluid Academy Scientific Meeting that current standard of care guidelines for IV fluid management of critical care patients are "likely to lead to salt water drowning of these patients." Cardiac dysfunction manifests in a significant proportion of patients with severe infections, life-threatening trauma as well as those undergoing major surgery; this leads to insufficient cardiac output. Administration of IV fluids is usually the first step in resuscitating these patients. However, too much fluid can cause serious complications, increase the length of ICU and hospital stays, and increase the risk of death. Clinical studies have consistently shown that only about half of hemodynamically unstable critically ill patients are responsive to fluids. Traditionally, patients undergoing surgery for traumatic injuries have been managed with a liberal IV fluid strategy, as recommended by the Advanced Trauma Life Support® (ATLS®) Student Course of the American College of Surgeons (ACS (News - Alert)). "There are, however, absolutely no human data to show that large volume IV fluid resuscitation reliably improves organ perfusion," said Dr. Marik. "In fact, this approach is likely to lead to iatrogenic salt water rowning, caused by acute respiratory distress syndrome (ARDS), acute kidney injury (AKI), myocardial injury, gastrointestinal dysfunction, and poor wound-healing with an increased risk of death." "The physicians' guide must be the measurement of cardiac output," said Dr. Marik. "Traditional parameters routinely monitored today in the ICU and operating room, heart rate and blood pressure, are neither sensitive nor specific enough for timely identification of hemodynamic deterioration. Resuscitation of critically ill patients via IV fluids requires the ability to continuously monitor their cardiac output response following a fluid challenge." "Key opinion leaders such as Dr. Marik are recognizing the increased patient benefits and the decreased costs associated with fluid management. The FDA-cleared and CE-marked CHEETAH NICOM system is completely noninvasive and using the power of Bioreactance®, is designed to be the very best technology for continuous fluid assessment in the operating room or a critical care setting," said Chris Hutchison, President and CEO of Cheetah Medical. It should be noted that Dr. Paul E. Marik has no financial ties to Cheetah Medical. The CHEETAH NICOM™ (NonInvasive Cardiac Output Monitoring) system is the only completely noninvasive product designed to provide real-time, continuous, and dynamic monitoring of IV fluids that has been validated against the previous "gold standards" of PAC (Pulmonary Artery Catheter), EDM (Esophageal Doppler Monitoring), and thermo dilution catheter. CLICK HERE TO VIEW VIDEO, "A Physician's Perspective." About Cheetah Medical Headquartered in Newton, Mass., and approved in 60 countries including the U.S., Cheetah Medical is a rapidly growing medical device company with a breakthrough technology, CHEETAH NICOM™, designed to set a new standard of care for noninvasive, beat-to-beat, user- and patient-friendly cardiac output monitoring. CHEETAH NICOM has met with success in patients undergoing Guided Fluid Therapy during surgery, in critical care patients who are being fluid resuscitated to manage sepsis, and in trauma patients who have experienced high fluid loss. To learn more, please visit www.cheetah-medical.com. |
